Blueprint Medicines share#snapshot#suffix
| 101,57USD | -2,36USD | -2,27% |
WKN DE: A14SDD / ISIN: US09627Y1091
Blueprint Medicines share#search#balancesheet/share#balance#headline#income_statement
share#balance#profitpershare- Blueprint Medicines
| -8,4 23 | -9,4 22 | -11,0 21 | 5,6 20 | -7,3 19 | -5,4 18 | -3,9 17 |
share#balance#salespershare- Blueprint Medicines
| 4,1 23 | 3,4 22 | 3,1 21 | 14,1 20 | 1,4 19 | 1,0 18 | 0,6 17 |
share#balance#p_e_ratio- Blueprint Medicines
| 20,1 20 |
Blueprint Medicines Corp: share#balance#headline#theshare (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | -8,37 | -9,35 | -11,01 | 5,59 | -7,27 | -5,39 | -3,92 |
| Gewinn je Aktie unverwässert | -8,37 | -9,35 | -11,01 | 5,76 | -7,27 | -5,39 | -3,92 |
| Gewinn je Aktie verwässert | -8,37 | -9,35 | -11,01 | 5,59 | -7,27 | -5,39 | -3,92 |
| share#balance#cell#dividend_per_share | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| share#balance#cell#dividend_payment | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Blueprint Medicines Corp: share#balance#business_ratio (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales_share | 4,12 | 3,42 | 3,08 | 14,13 | 1,39 | 1,01 | 0,57 |
| share#balance#cell#basic_kgv_end | - | - | - | 20,07 | - | - | - |
| share#balance#cell#diluted_kgv_end | - | - | - | 20,07 | - | - | - |
| share#balance#cell#dividend_ratio | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| share#balance#cell#equity_ratio | 12,45 | 38,13 | 77,52 | 85,55 | 65,62 | 77,58 | 87,18 |
| share#balance#cell#debt_ratio | 87,55 | 61,87 | 22,48 | 14,45 | 34,38 | 22,42 | 12,82 |
Blueprint Medicines Corp: share#balance#headline#income_statement (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales | 249,38 | 204,04 | 180,08 | 793,74 | 66,51 | 44,52 | 21,43 |
| share#balance#cell#sales_change | 22,22 | 13,30 | -77,31 | 1 093,37 | 49,39 | 107,79 | -22,85 |
| share#balance#cell#sales_gross_profit | 224,92 | 157,18 | 141,56 | 780,96 | - | - | - |
| share#balance#cell#sales_gross_profit_change | 43,10 | 11,03 | -81,87 | - | - | - | - |
| share#balance#cell#operating_income | -486,28 | -537,52 | -641,98 | 308,71 | -361,33 | -247,03 | -151,25 |
| share#balance#cell#operating_income_change | 9,53 | 16,27 | - | - | -46,27 | -63,33 | -108,40 |
| share#balance#cell#income_before_tax | -506,02 | -552,28 | -641,08 | 314,94 | -347,69 | -236,64 | -148,12 |
| share#balance#cell#income_before_tax_change | 8,38 | 13,85 | - | - | -46,93 | -59,76 | -104,32 |
| share#balance#cell#income_after_tax | -506,98 | -557,52 | -644,09 | 313,88 | -347,69 | -236,64 | -148,12 |
| share#balance#cell#income_after_tax_change | 9,06 | 13,44 | - | - | -46,93 | -59,76 | -104,32 |
Blueprint Medicines Corp: share#balance#headline#balance (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#total_liabilities | 919 | 835 | 281 | 248 | 243 | 121 | 92 |
| Langzeit Gesamtverbindlichk. pro Aktie | 11,51 | 10,87 | 2,23 | 2,03 | 2,78 | 1,38 | 1,12 |
| share#balance#cell#total_equity | 131 | 515 | 971 | 1 470 | 464 | 419 | 624 |
| share#balance#cell#total_equity_change | -74,62 | -46,98 | -33,97 | 216,58 | 10,82 | -32,85 | 192,84 |
| share#balance#cell#total_liabilities_and_equity | 1 049 | 1 350 | 1 252 | 1 718 | 708 | 540 | 716 |
| share#balance#cell#total_liabilities_and_equity_change | -22,27 | 7,80 | -27,13 | 142,82 | 31,02 | -24,54 | 153,09 |
Blueprint Medicines Corp: share#balance#headline#other_data (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | -8,37 | -9,35 | -11,01 | 5,76 | -7,27 | -5,39 | -3,92 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 10,44 | 15,07 | -291,23 | - | -34,76 | -37,61 | -48,48 |
| Gewinn je Aktie (verwässert) | -8,37 | -9,35 | -11,01 | 5,59 | -7,27 | -5,39 | -3,92 |
| Veränderung Gewinn je Aktie (verwässert) in % | 10,44 | 15,07 | -296,96 | - | -34,76 | -37,61 | -48,48 |
| share#balance#cell#employees | 655 | 641 | 495 | 429 | 383 | 217 | 149 |
| share#balance#cell#employees_change | 2,18 | 29,49 | 15,38 | 12,01 | 76,50 | 45,64 | 40,57 |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.